Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek cooperative group for pancreatic cancer

Annals of Oncology

Volumn 12, Issue 1, 2001, Pages 101-103

  Stathopoulos, G P ^a   Mavroudis, D ^b   Tsavaris, N ^c   Kouroussis, C ^b   Aravantinos, G ^d   Agelaki, S ^b   Kakolyris, S ^b   Rigatos, S K ^a   Karabekios, S ^b   Georgoulias, V ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d Agii Anargyri Anticancer Hospital of Athens   (Greece)

Author keywords

Chemotherapy; Docetaxel; Gemcitabine; Pancreatic cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; ANALGESIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DOCETAXEL; FLUOROURACIL; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; OPIATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ADULT; ADVANCED CANCER; AGED; APPETITE; ARTICLE; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; FLU LIKE SYNDROME; GREECE; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METASTASIS; MULTICENTER STUDY; NAUSEA AND VOMITING; NEUTROPENIA; PAIN ASSESSMENT; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT; THROMBOCYTOPENIA; TUMOR GROWTH; WEIGHT GAIN;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PACLITAXEL; PANCREATIC NEOPLASMS; TAXOIDS; TREATMENT OUTCOME;

EID: 0035131918     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008310106171     Document Type: Article

References (12)

1. Chemotherapy of adenocarcinoma of the pancreas
2. Evaluation of the antitumor activity of gemcitabine (2′.2′-difluoro-2′-deoxycytidine)
3. Phase II trial of gemcitabine (2.2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
4. Phase II study of gemcitabine in patients with advanced pancreatic cancer
5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
6. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
7. Relationships between the structure of Taxol analogues and their antimitotic activity
8. Experimental antitumor activity of Taxotere (PR 56976, NSC 628503), a taxol analogue
9. Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study
10. Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
11. A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the study of Digestive Tract Cancer (GISCAD)
12. Phase I-II study of gemcitabine and fluoracil in a continuous infusion in patients with pancreatic cancer